AU Patent

AU2002367172A1 — 2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents

Assigned to Bayer Pharmaceuticals Corp · Expires 2003-07-15 · 23y expired

What this patent protects

Patent listed against fostamatinib-disodium.

Drugs covered by this patent

fostamatinib-disodium (FOSTAMATINIB DISODIUM)

Patent Metadata

Patent number: AU2002367172A1
Jurisdiction: AU
Classification: —
Expires: 2003-07-15
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Pharmaceuticals Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.